| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥211.26B | +11.1% |
| Gross profit | ¥211.26B | — |
| Operating income | ¥99.33B | — |
| Net income | ¥86.82B | +3.7% |
| Gross margin | 100.0% | Net margin 41.1% |
| Revenue Q/Q | +12.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | ¥43.51B | 20.6% |
| Tax & other | ¥12.51B | 5.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中国核电 ・ 中国银行 ・ 中金公司 ・ 中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies